Article Correctness Is Author's Responsibility: Clinical trials of low-dose rapamycin to protect elderly from COVID-19 proposed

The article below may contain offensive and/or incorrect content.

This shows a face maskResearchers propose a strategy for repurposing geroprotectors, including rapamycin and metformin, as potential COVID-19 infections prevention methods.